Ono Pharmaceutical Co., Ltd. (OPHLY)
4.799
-0.04
(-0.85%)
USD |
OTCM |
Oct 02, 16:00
Ono Pharmaceutical Gross Profit Margin (Quarterly) : 75.31% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.31% |
| March 31, 2026 | 72.16% |
| December 31, 2025 | 73.78% |
| September 30, 2025 | 73.02% |
| June 30, 2025 | 70.98% |
| March 31, 2025 | 59.72% |
| December 31, 2024 | 65.85% |
| September 30, 2024 | 77.82% |
| June 30, 2024 | 74.79% |
| March 31, 2024 | 71.92% |
| December 31, 2023 | 76.60% |
| September 30, 2023 | 78.97% |
| June 30, 2023 | 74.86% |
| March 31, 2023 | 75.71% |
| December 31, 2022 | 75.41% |
| September 30, 2022 | 75.65% |
| June 30, 2022 | 74.76% |
| March 31, 2022 | 74.56% |
| December 31, 2021 | 74.25% |
| September 30, 2021 | 73.74% |
| June 30, 2021 | 73.90% |
| March 31, 2021 | 73.88% |
| December 31, 2020 | 71.12% |
| September 30, 2020 | 71.95% |
| June 30, 2020 | 72.55% |
| Date | Value |
|---|---|
| March 31, 2020 | 73.92% |
| December 31, 2019 | 73.93% |
| September 30, 2019 | 72.09% |
| June 30, 2019 | 71.98% |
| March 31, 2019 | 73.66% |
| December 31, 2018 | 68.32% |
| September 30, 2018 | 70.63% |
| June 30, 2018 | 71.72% |
| March 31, 2018 | 75.26% |
| December 31, 2017 | 75.05% |
| September 30, 2017 | 74.64% |
| June 30, 2017 | 75.14% |
| March 31, 2017 | 72.73% |
| December 31, 2016 | 74.63% |
| September 30, 2016 | 72.82% |
| June 30, 2016 | 72.43% |
| March 31, 2016 | 75.88% |
| December 31, 2015 | 72.87% |
| September 30, 2015 | 73.05% |
| June 30, 2015 | 74.15% |
| March 31, 2015 | 70.59% |
| December 31, 2014 | 77.59% |
| September 30, 2014 | 72.55% |
| June 30, 2014 | 73.90% |
| March 31, 2014 | 75.05% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 57.57% |
| Daiichi Sankyo Co., Ltd. | 78.37% |
| Astellas Pharma, Inc. | 75.29% |
| Eisai Co., Ltd. | 78.20% |
| Chugai Pharmaceutical Co., Ltd. | 69.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.20% |
| Return on Assets | 7.15% |
| Return on Invested Capital | 7.98% |
| Profit Margin (Quarterly) | 20.80% |
| Operating Margin (Quarterly) | 26.84% |
| Return on Net Operating Assets | 11.09% |